News & Updates
Filter by Specialty:
Fezolinetant reduces menopause-related vasomotor symptoms
18 Aug 2023
byStephen Padilla
Treatment with fezolinetant 30 and 45 mg daily provides relief from moderate-to-severe vasomotor symptoms (VSM) associated with menopause, suggests a study.
Fezolinetant reduces menopause-related vasomotor symptoms
18 Aug 2023
Long-term hydrochlorothiazide use ups risk of skin cancer
17 Aug 2023
Using hydrochlorothiazide (HCTZ) for longer durations and in higher cumulative doses increases the risks for keratinocyte carcinoma and melanoma, reveals a study.
Long-term hydrochlorothiazide use ups risk of skin cancer
17 Aug 2023
Demedicalized delivery of PrEP possible, improves access
16 Aug 2023
byStephen Padilla
A peer-led demedicalized delivery of same-day HIV pre-exposure prophylaxis (PrEP) in various community centres is feasible, suggests a Philippines study presented at the recent IAS 2023.
Demedicalized delivery of PrEP possible, improves access
16 Aug 2023
Meeting gender-affirming needs tied to accessing HIV services among transgender people
16 Aug 2023
byStephen Padilla
Having met gender-affirming care needs among transgender people is associated with accessing HIV-related services in a community-led clinic, as shown in a Philippines study presented at IAS 2023.